MONTANOVA CAPITAL, LLC
New York, NY · CIK 1569064 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$7.9bn
- Staff23 · 12 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $7.8bn gross assets
- Websitemontanova.com
- Form ADV · 2026-07-01SEC adviser record
- Legal entityMontanova Capital, LLC (US)
Options: 0 call positions (— notional), 1 put positions ($709.4m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| VERADERMICS INC MANE | $512.5m10.77% | Unchanged |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $326.1m6.85% | Added +110.0k |
| LEGEND BIOTECH CORP LEGN | $204.2m4.29% | Reduced -511.0k |
| PALVELLA THERAPEUTICS INC NE PVLA | $173.5m3.65% | Reduced -18.1k |
| ARRIVENT BIOPHARMA INC AVBP | $156.9m3.30% | Added +114.4k |
| BENITEC BIOPHARMA INC BNTC | $154.5m3.25% | Unchanged |
| BIOHAVEN LTD BHVN | $153.1m3.22% | Unchanged |
| ADVANCED MICRO DEVICES INC AMD | $149.4m3.14% | Unchanged |
| ARCUS BIOSCIENCES INC RCUS | $147.3m3.09% | Reduced -254.6k |
| TAIWAN SEMICONDUCTOR MFG LTD TSM | $145.5m3.06% | Added +5.9k |
| NVIDIA CORPORATION NVDA | $144.2m3.03% | Added +146.0k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $118.6m2.49% | Unchanged |
| SYSCO CORP SYY | $118.0m2.48% | Added +252.4k |
| GE AEROSPACE GE | $116.0m2.44% | Unchanged |
| IMMATICS N.V IMTX | $113.4m2.38% | Unchanged |
| MGM RESORTS INTERNATIONAL MGM | $111.2m2.34% | Added +166.6k |
| META PLATFORMS INC META | $99.0m2.08% | Added +6.1k |
| CAPRICOR THERAPEUTICS INC CAPR | $98.6m2.07% | Added +274.2k |
| KURA ONCOLOGY INC KURA | $94.1m1.98% | Unchanged |
| MONTE ROSA THERAPEUTICS INC GLUE | $85.9m1.81% | Reduced -677.3k |
| AVALYN PHARMACEUTICALS INC AVLN | $82.4m1.73% | New |
| HOME DEPOT INC HD | $79.7m1.68% | Added +4.5k |
| HUT 8 CORP HUT | $77.3m1.63% | New |
| CAPITAL ONE FINL CORP COF | $66.8m1.40% | Added +30.7k |
| VULCAN MATLS CO VMC | $63.4m1.33% | Added +33.4k |
| FERGUSON ENTERPRISES INC FERG | $58.6m1.23% | Added +34.9k |
| ZURA BIO LTD ZURA | $55.7m1.17% | Added +376.0k |
| INFLARX NV IFRX | $51.4m1.08% | Added +15.0m |
| AURA BIOSCIENCES INC AURA | $51.2m1.08% | Added +2.8m |
| FAETH THERAPEUTICS INC FTH | $50.5m1.06% | Added +2.0m |
| ADVISORSHARES TR MSOS | $49.5m1.04% | Added +692.3k |
| AMAZON COM INC AMZN | $48.8m1.03% | Reduced -49.1k |
| REPLIMUNE GROUP INC REPL | $48.6m1.02% | Added +168.0k |
| AMPHENOL CORP APH | $47.5m1.00% | New |
| SPOTIFY TECHNOLOGY S A SPOT | $46.7m0.98% | Added +100.7k |
| CONTINEUM THERAPEUTICS INC CTNM | $46.6m0.98% | Unchanged |
| APOLLO GLOBAL MGMT INC APO | $45.3m0.95% | Reduced -4.4k |
| BANK AMERICA CORP BAC | $45.0m0.95% | Reduced -505.5k |
| ROUNDHILL ETF TRUST DRAM | $44.5m0.94% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $44.4m0.93% | Added +142.4k |
| CEREBRAS SYSTEMS INC CBRS | $38.0m0.80% | New |
| DICKS SPORTING GOODS INC DKS | $34.3m0.72% | New |
| BROADCOM INC AVGO | $31.6m0.66% | New |
| COMPASS THERAPEUTICS INC CMPX | $30.9m0.65% | Reduced -206.2k |
| LEXEO THERAPEUTICS INC LXEO | $29.7m0.62% | Added +5.1m |
| UNITEDHEALTH GROUP INC UNH | $26.7m0.56% | Reduced -36.5k |
| PROKIDNEY CORP PROK | $25.2m0.53% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $19.7m0.41% | Added +600.0k |
| SPACE EXPLORATION TECHN CORP SPCX | $17.3m0.36% | New |
| MARTIN MARIETTA MATLS INC MLM | $15.0m0.32% | New |
| FULCRUM THERAPEUTICS INC FULC | $13.5m0.28% | Reduced -2.9m |
| PLANET FITNESS INC PLNT | $11.5m0.24% | New |
| BLOOM ENERGY CORP BE | $10.2m0.22% | New |
| KARDIGAN INC KARD | $9.5m0.20% | New |
| CVS HEALTH CORP CVS | $8.7m0.18% | New |
| MOLECULAR PARTNERS AG MOLN | $8.6m0.18% | Unchanged |
| ANTERIS TECHNOLOGIES GLOBAL AVR | $8.4m0.18% | Unchanged |
| DEXCOM INC DXCM | $6.9m0.14% | Added +70.3k |
| THERMO FISHER SCIENTIFIC INC TMO | $6.7m0.14% | Unchanged |
| CENTENE CORP DEL CNC | $6.4m0.13% | New |
| ABBOTT LABS ABT | $6.1m0.13% | Unchanged |
| BOSTON SCIENTIFIC CORP BSX | $6.0m0.13% | Added +16.1k |
| INTUITIVE SURGICAL INC ISRG | $5.4m0.11% | Added +2.3k |
| DANAHER CORPORATION DHR | $5.1m0.11% | Reduced -9.8k |
| MINERALYS THERAPEUTICS INC MLYS | $4.7m0.10% | Reduced -1.4m |
| CELLDEX THERAPEUTICS INC NEW CLDX | $4.5m0.09% | New |
| SATELLOS BIOSCIENCE INC MSLE | $3.7m0.08% | Unchanged |
| CENCORA INC COR | $3.5m0.07% | Unchanged |
| TRULIEVE CANNABIS CORP SUB VTG SHS | $3.5m0.07% | New |
| ABEONA THERAPEUTICS INC ABEO | $3.1m0.06% | Reduced -2.2m |
| NATERA INC NTRA | $2.7m0.06% | Unchanged |
| JOHNSON & JOHNSON JNJ | $2.0m0.04% | Reduced -15.7k |
| LAM RESEARCH CORP LRCX | $1.9m0.04% | New |
| MICROSOFT CORP MSFT | $1.9m0.04% | Unchanged |
| STRYKER CORPORATION SYK | $1.8m0.04% | Unchanged |
| EDWARDS LIFESCIENCES CORP EW | $1.7m0.04% | Unchanged |
| MEDLINE INC MDLN | $1.7m0.04% | Unchanged |
| PERFORMANCE FOOD GROUP CO PFGC | $1.6m0.03% | Reduced -372.2k |
| SNOWFLAKE INC SNOW | $1.4m0.03% | New |
| IQVIA HLDGS INC IQV | $1.4m0.03% | Unchanged |
| MCKESSON CORP MCK | $1.4m0.03% | Unchanged |
| HCA HEALTHCARE INC HCA | $1.2m0.03% | Unchanged |
| WATERS CORP WAT | $1.2m0.03% | Unchanged |
| ALPHABET INC GOOG | $1.2m0.03% | New |
| GRAINGER W W INC GWW | $1.0m0.02% | Reduced -230 |
| IONIS PHARMACEUTICALS INC IONS | $856.3k0.02% | Unchanged |
| US FOODS HLDG CORP USFD | $707.6k0.01% | Reduced -389.1k |
| AGILENT TECHNOLOGIES INC A | $662.8k0.01% | Unchanged |
| VERALTO CORP VLTO | $485.5k0.01% | Unchanged |
| RESMED INC RMD | $465.8k0.01% | Unchanged |
| STERIS PLC STE | $322.2k0.01% | Unchanged |
| SAREPTA THERAPEUTICS INC SRPT | $321.4k0.01% | Unchanged |
| ZIMMER BIOMET HOLDINGS INC ZBH | $280.7k0.01% | Unchanged |
| CHARLES RIV LABS INTL INC CRL | $229.1k0.00% | New |
| INMED PHARMACEUTICALS INC INM | $155.0k0.00% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| APELLIS PHARMACEUTICALS INC APLS | $141.5m3.5m shares |
| KALVISTA PHARMACEUTICALS INC KALV | $96.0m4.8m shares |
| ERASCA INC ERAS | $55.6m3.4m shares |
| LIFE TIME GROUP HOLDINGS INC LTH | $13.7m510.3k shares |
| WINGSTOP INC WING | $9.2m59.5k shares |
| COHERENT CORP COHR | $7.1m30.0k shares |
| MEDTRONIC PLC MDT | $6.3m72.3k shares |
| KEZAR LIFE SCIENCES INC KZR | $5.3m716.8k shares |
| METTLER TOLEDO INTERNATIONAL MTD | $2.5m2.0k shares |
| TESLA INC TSLA | $1.9m5.2k shares |
| TALEN ENERGY CORP TLN | $1.9m6.0k shares |
| VISTRA CORP VST | $902.0k6.0k shares |
| ROBLOX CORP RBLX | $476.2k8.4k shares |
| VIRIDIAN THERAPEUTICS INC VRDN | $326.7k16.7k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $709.4m950.0k shares | Added |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| BENITEC BIOPHARMA INC BNTC · 13D · filed 2025-11-10 | 44.1%≈ $223.0m |
| INFLARX NV IFRX · 13G · filed 2026-08-14 | 15.6%≈ $27.8m |
| MOLECULAR PARTNERS AG MOLN · 13G · filed 2025-05-02 | 10.6% |
| AADI BIOSCIENCE INC WHWK · 13G · filed 2025-03-11 | 10.0%≈ $21.7m |
| ZURA BIO LTD ZURA · 13G · filed 2026-05-12 | 9.9%≈ $56.2m |
| ARRIVENT BIOPHARMA INC AVBP · 13G · filed 2025-08-13 | 9.9%≈ $118.6m |
| DBV TECHNOLOGIES S A DBVT · 13G · filed 2025-04-11 | 9.9% |
| KURA ONCOLOGY INC KURA · 13G · filed 2026-08-14 | 9.7%≈ $94.1m |
| VERADERMICS INC MANE · 13D · filed 2026-08-21 | 8.8%≈ $457.2m |
| IMMATICS N.V IMTX · 13G · filed 2026-02-13 | 8.3%≈ $113.4m |
| COMPASS THERAPEUTICS INC CMPX · 13G · filed 2025-08-21 | 8.2%≈ $30.9m |
| REPLIMUNE GROUP INC REPL · 13G · filed 2026-08-06 | 7.9%≈ $73.2m |
| FAETH THERAPEUTICS INC FTH · 13G · filed 2026-06-23 | 7.8%≈ $50.5m |
| BIOHAVEN LTD BHVN · 13G · filed 2026-02-13 | 7.8%≈ $153.1m |
| LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-04-13 | 7.7%≈ $26.4m |
| AURA BIOSCIENCES INC AURA · 13G · filed 2025-08-13 | 7.6%≈ $33.4m |
| PALVELLA THERAPEUTICS INC NE PVLA · 13G · filed 2025-11-13 | 7.4%≈ $125.7m |
| CAPRICOR THERAPEUTICS INC CAPR · 13G · filed 2026-02-26 | 6.6%≈ $82.3m |
| AVALYN PHARMACEUTICALS INC AVLN · 13D · filed 2026-05-08 | 5.6%≈ $82.4m |
| 89BIO INC ETNB · 13G · filed 2025-11-13 | 5.6% |
| FULCRUM THERAPEUTICS INC FULC · 13G · filed 2026-08-14 | 5.5%≈ $13.5m |
| MARINUS PHARMACEUTICALS INC MRNS · 13G · filed 2025-02-11 | 5.5% |
Trades reported as a company insider since 1 Apr 2026
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2026-08-19 | VERADERMICS INC Director · See footnotes | Sold | $80.4m750.0k shares |